SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-23-002362
Filing Date
2023-07-03
Accepted
2023-07-03 15:49:40
Documents
5
Period of Report
2023-07-03

Document Format Files

Seq Description Document Type Size
1 6-K zk2329929.htm 6-K 11406
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 228587
3 EXHIBIT 99.2 exhibit_99-2.htm EX-99.1 47876
4 image0.jpg GRAPHIC 88881
5 image00001.jpg GRAPHIC 1384
  Complete submission text file 0001178913-23-002362.txt   413496
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38807 | Film No.: 231065160
SIC: 2834 Pharmaceutical Preparations